Mission Pharmacal Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Mission Pharmacal

Access the complete profile.

Mission Pharmacal Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	Po Box 786099 San Antonio, TX 78278

Note: Revenues for privately held companies are statistical evaluations.


Mission Pharmacal's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Mission Pharmacal's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Mission Pharmacal is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Mission Pharmacal Annual Revenue and Growth Rate

Mission Pharmacal	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Mission Pharmacal's revenues are gauged from an analysis of company filings.

Mission Pharmacal's Income Statement (based on Industry Averages)

Mission Pharmacal P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Mission Pharmacal is developing and marketing. Mission Pharmacal doesn't have any recent trademark applications, indicating Mission Pharmacal is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
THIOLA XR Pharmaceutical preparations, namely, preparations for the prevention and treatment of kidney stones, kidney disorders, and diseases of the kidney	08/09/2022
THIOLA XL Pharmaceutical preparations, namely, preparations for the prevention and treatment of kidney stones, kidney disorders, and diseases of the kidney	08/09/2022
THIOLA CR Pharmaceutical preparations, namely, preparations for the prevention and treatment of kidney stones, kidney disorders, and diseases of the kidney	08/09/2022

See all trademarks and details in the Full Report.

Market Share of Mission Pharmacal's Largest Competitors

A competitive analysis shows these companies are in the same general field as Mission Pharmacal, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Mission Pharmacal. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DPT LABORATORIES	San Antonio, TX	100
MISSION PHARMACAL	San Antonio, TX	50
LUMINUS BIOSCIENCES	San Antonio, TX	1
SOUTH TEXAS HERBS	San Antonio, TX	1
PCARX	San Antonio, TX	1

Future Competition: Mission Pharmacal's Fastest Growing Competitors

These companies are in the same general field as Mission Pharmacal and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)